Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Newest in this topic

  1. Symptomatic lobar intracerebral hemorrhage during extended lecanemab treatment: A case report 2026-01-01
  2. Cerebrospinal fluid in the differential diagnosis of Alzheimer's disease: clinical utility of an extended panel of biomarkers in a specialist cognitive clinic 2018-03-20
  3. Amyloid-beta-anti-amyloid-beta complex structure reveals an extended conformation in the immunodominant B-cell epitope 2008-01-30

Studies

3 studies carry this tag.

Date range

2008 to 2026

Top journals

  • Alzheimer's research & therapy 1
  • Journal of Alzheimer's disease reports 1
  • Journal of molecular biology 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Symptomatic lobar intracerebral hemorrhage during extended lecanemab treatment: A case report

    ✓ Peer-reviewed alzhub usefulness score 48 out of 100. Journal of Alzheimer's disease reports 2026-01-01 Treatments

    Lecanemab is an anti-amyloid-β protofibril antibody that slows cognitive decline in early Alzheimer's disease.

  2. Cerebrospinal fluid in the differential diagnosis of Alzheimer's disease: clinical utility of an extended panel of biomarkers in a specialist cognitive clinic

    ✓ Peer-reviewed alzhub usefulness score 53 out of 100. Alzheimer's research & therapy 2018-03-20 Biomarkers

    There were significant global differences in Aβ1-42, T-tau, T-tau/Aβ1-42 ratio, P-tau-181, NFL, AβX-42, AβX-42/X-40 ratio, APPα, and APPβ between groups.

  3. Amyloid-beta-anti-amyloid-beta complex structure reveals an extended conformation in the immunodominant B-cell epitope

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Journal of molecular biology 2008-01-30 Treatments

    Alzheimer's disease (AD) is the most common form of dementia.

All topic tags with their study counts